Additional investigation into the levels of pro-inflammatory cells present in the company of Sesn2 deficiency or overexpression may elucidate further understanding into the mechanism in which Sesn2 protects cardiac tissue from fibrotic changes during obesity-induced chronic inflammation. The gene discussed is SESN2; the disease is obesity disorder.